Patents by Inventor Guangmiao Fu

Guangmiao Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9629863
    Abstract: Natural occurring inhibitors of cyclin-dependent protein kinase 5 (Cdk5), isolated from the root of Rhodiola rosea are structurally different from the known Cdk inhibitors. They show selectivity among different Cdks and efficacy to inhibit Cdk via a mixed-type of inhibition, which should lead to less toxicity and side-effects. They are useful in preventing and treating diseases and disorders associated with aberrant Cdk5 activities, such as acute and/or chronic pain, neuropathic pain, diabetes mellitus, cancer, neurodegenerative diseases and neuropathological disorders.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: April 25, 2017
    Assignee: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Nancy Yuk-Yu Ip, Fanny Chui-Fun Ip, Wing Yu Fu, Guangmiao Fu
  • Patent number: 9283204
    Abstract: This invention relates to extracts and refined fractions of a traditional Chinese medicinal herb, Alpinia officinarum (AO), components thereof, and the use of such compounds and compositions to treat neurodegenerative or neuropathological conditions or to inhibit aggregation of a-synuclein.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: March 15, 2016
    Assignee: The Hong Kong University of Science and Technology
    Inventors: Nancy Yuk Yu Ip, Kenny Ka Kin Chung, Fanny Chui Fun Ip, Guangmiao Fu
  • Publication number: 20150119348
    Abstract: Natural occurring inhibitors of cyclin-dependent protein kinase 5 (Cdk5), isolated from the root of Rhodiola rosea are structurally different from the known Cdk inhibitors. They show selectivity among different Cdks and efficacy to inhibit Cdk via a mixed-type of inhibition, which should lead to less toxicity and side-effects. They are useful in preventing and treating diseases and disorders associated with aberrant Cdk5 activities, such as acute and/or chronic pain, neuropathic pain, diabetes mellitus, cancer, neurodegenerative diseases and neuropathological disorders.
    Type: Application
    Filed: December 30, 2014
    Publication date: April 30, 2015
    Inventors: Nancy Yuk-Yu IP, Fanny Chui-Fun IP, Wing Yu FU, Guangmiao FU
  • Publication number: 20130137762
    Abstract: This invention relates to extracts and refined fractions of a traditional Chinese medicinal herb, Alpinia officinarum (AO), components thereof, and the use of such compounds and compositions to treat neurodegenerative or neuropathological conditions or to inhibit aggregation of a-synuclein.
    Type: Application
    Filed: August 10, 2011
    Publication date: May 30, 2013
    Applicant: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Nancy Yuk Yu Ip, Kenny Ka Kin Chung, Fanny Chui Fun Ip, Guangmiao Fu
  • Publication number: 20120270821
    Abstract: Natural occurring inhibitors of cyclin-dependent protein kinase 5 (Cdk5), isolated from the root of Rhodiola rosea are structurally different from the known Cdk inhibitors. They show selectivity among different Cdks and efficacy to inhibit Cdk via a mixed-type of inhibition, which should lead to less toxicity and side-effects. They are useful in preventing and treating diseases and disorders associated with aberrant Cdk5 activities, such as acute and/or chronic pain, neuropathic pain, diabetes mellitus, cancer, neurodegenerative diseases and neuropathological disorders.
    Type: Application
    Filed: December 7, 2010
    Publication date: October 25, 2012
    Applicant: The Hong Kong University of Science and Technology
    Inventors: Nancy Yuk-Yu IP, Fanny Chui-Fun IP, Wing Yu Fu, Guangmiao Fu